Menu
GOVPH
  • Home
  • HTA Governance
    • Universal Health Care Act
    • Administrative Order on HTA
    • Philippine HTA Process Guide
    • Philippine HTA Methods Guide
    • Philippine HTA Code of Conduct
  • About Us
    • Mission/Vision
    • Health Technology Assessment Council (HTAC)
    • Health Technology Assessment Division (HTAD)
    • HTA Philippines Annual Report
      • 2021 HTA Annual Report
      • 2020 HTA Annual Report
      • 2019 HTA Annual Report
    • Road to HTA Institutionalization
    • External Partners
  • Assessments
    • Status of Assessments
    • Timeline of Assessments
  • Issuances
  • Evidence Briefs
  • FAQs
  • Get Involved with Us
    • Contact Us
    • Call for Nomination
    • Topic Nomination
  • AUXILIARY MENU
  • GOVPH
  • Home
  • HTA Governance
    • Universal Health Care Act
    • Administrative Order on HTA
    • Philippine HTA Process Guide
    • Philippine HTA Methods Guide
    • Philippine HTA Code of Conduct
  • About Us
    • Mission/Vision
    • Health Technology Assessment Council (HTAC)
    • Health Technology Assessment Division (HTAD)
    • HTA Philippines Annual Report
      • 2021 HTA Annual Report
      • 2020 HTA Annual Report
      • 2019 HTA Annual Report
    • Road to HTA Institutionalization
    • External Partners
  • Assessments
    • Status of Assessments
    • Timeline of Assessments
  • Issuances
  • Evidence Briefs
  • FAQs
  • Get Involved with Us
    • Contact Us
    • Call for Nomination
    • Topic Nomination

New Briefs

HTAC recommendation on the minor inclusion of potassium citrate [1620 mg (15mEq)] tablet in the PNF

May 19, 2022

HTAC recommendation on the inclusion of Tocilizumab in the PNF

May 16, 2022

SECRETARY OF HEALTH APPROVAL OF THE HTAC RECOMMENDATION ON FOURTH DOSE FOR IMMUNOCOMPROMISED POPULATIONS (ICPs)

April 22, 2022

HTAC recommendation on the reinclusion of vasopressin in the PNF

March 9, 2022

Pediatric Vaccination for the prevention of COVID-19 for 5 to 11 age group

February 11, 2022

GABAY NG HTAC: PAGSAMA NG ORAL PREP SA PNF

February 10, 2022

HTAC GUIDANCE: Oral PrEP for inclusion in the PNF

February 10, 2022

HTAC recommendation on the minor inclusion of sambong 250mg tablet for anti-urolithiasis (kidney stones) in the Philippine National Formulary (PNF)

January 18, 2022

HTAC interim recommendation on the use of casirivimab+imdevimab for the treatment of COVID-19

December 29, 2021

HTAC Recommendation: COVID-19 Vaccine Sputnik V

December 29, 2021

Posts navigation

    • 1
    • 2
    • 3
  • Older Older
656182
Users Today : 680
This Month : 20978
Total Users : 656182
Your IP Address : 44.192.47.87
Philippine Standard Time: